Jan Trka

10.7k citations

149 papers · 3.7k · h-index 34

Impact in

Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Public Health, Environmental and Occupational Health top 0.5%
- Acute Lymphoblastic Leukemia research

Papers in

Public Health, Environmental and Occupational Health 104
- Acute Lymphoblastic Leukemia research 104
Hematology 88
- Acute Myeloid Leukemia Research 59
- Chronic Myeloid Leukemia Treatments 42

Co-authors: Jan Starý (66 shared papers)Jan Zuna (45 shared papers)Markéta Žaliová (41 shared papers)Ondřej Hrušák (35 shared papers)Júlia Starková (33 shared papers)Dirk Reinhardt (19 shared papers)Eva Froňková (32 shared papers)Marry M. van den Heuvel‐Eibrink (16 shared papers)
Journals: Blood (40 papers)Leukemia (26 papers)Haematologica (9 papers)Pediatric Blood & Cancer (6 papers)British Journal of Haematology (5 papers)
Partner nations: Czechia Germany Netherlands

In The Last Decade

Jan Trka

141 papers receiving 3.6k citations

Peers

Countries citing papers authored by Jan Trka

Since Specialization

Citations

This map shows the geographic impact of Jan Trka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Trka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Trka more than expected).

Fields of papers citing papers by Jan Trka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Trka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Trka. The network helps show where Jan Trka may publish in the future.

Co-authors

The 25 scholars most cited alongside Jan Trka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan Trka Line = papers co-authored together Jan Trka links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 149 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data Leukemia ·Vincent H. J. van der Velden, Giovanni Cazzaniga, André Schrauder, Jeremy Hancock, Peter Bader, E. Renate Panzer-Grümayer, T Flohr, Rosemary Sutton, Hélène Cavé, Hans O. Madsen, J M Cayuela, Jan Trka, Cornelia Eckert, Letizia Foroni, Udo zur Stadt, Kheïra Beldjord, Thorsten Raff, C. Ellen van der Schoot, Jacques J. M. van Dongen, (unknown)	2007	464
2	NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern Blood ·Iris H.I.M. Hollink, Marry M. van den Heuvel‐Eibrink, Susan T.C.J.M. Arentsen-Peters, Marta Pratcorona, Saman Abbas, Jenny E. Kuipers, Janneke F. van Galen, H. Berna Beverloo, Edwin Sonneveld, Gertjan J.L. Kaspers, Jan Trka, André Baruchel, Martin Zimmermann, Ursula Creutzig, Dirk Reinhardt, Rob Pieters, Peter J.M. Valk, C. Michel Zwaan	2011	193
3	BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations Journal of Clinical Investigation ·Anindita Basak, Miroslava Hančárová, Jacob C. Ulirsch, Tuğçe B. Balcı, Marie Trková, Michal Pelisek, Markéta Vlčková, Kateřina Mužíková, Jaroslav Čermák, Jan Trka, David A. Dyment, Stuart H. Orkin, Mark J. Daly, Zdeněk Sedláček, Vijay G. Sankaran	2015	115
4	IKZF1 status as a prognostic feature in BCR-ABL1–positive childhood ALL Blood ·Arian van der Veer, Markéta Žaliová, Federica Mottadelli, Paola De Lorenzo, Geertruy te Kronnie, Christine J. Harrison, Hélène Cavé, Jan Trka, Vaskar Saha, Martin Schrappe, Rob Pieters, Andrea Biondi, Maria Grazia Valsecchi, Martin Stanulla, Monique L. den Boer, Giovanni Cazzaniga	2013	100
5	NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern Leukemia ·Jasmijn de Rooij, Iris H.I.M. Hollink, Susan T.C.J.M. Arentsen-Peters, Janneke F. van Galen, H. Berna Beverloo, André Baruchel, Jan Trka, Dirk Reinhardt, Edwin Sonneveld, M Zimmermann, Todd A. Alonzo, Rob Pieters, Soheil Meshinchi, Marry M. van den Heuvel‐Eibrink, C. Michel Zwaan	2013	95
6	Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry Leukemia ·Jan Trka, Markéta Kalinová, O Hrušák, Jan Zuna, Ondřej Krejčí, Jozef Madžo, Petr Sedláček, V. Vávra, K Michalová, Marie Jarošová, Jan Starý, (unknown)	2002	94
7	Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53 Leukemia ·N. E. Gefen, Vera Binder, Markéta Žaliová, Yvonne Linka, Michelle Morrow, Astrid Novosel, Liat Edry, Libi Hertzberg, Noam Shomron, Owen Williams, Jan Trka, Arndt Borkhardt, Shai Izraeli	2009	92
8	Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia Blood ·Iris H.I.M. Hollink, Marry M. van den Heuvel‐Eibrink, Martin Zimmermann, Brian V. Balgobind, Susan T.C.J.M. Arentsen-Peters, Mariëlle Alders, André Willasch, Gertjan J.L. Kaspers, Jan Trka, André Baruchel, Siebold S.N. de Graaf, Ursula Creutzig, Rob Pieters, Dirk Reinhardt, C. Michel Zwaan	2009	80
9	Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring Leukemia ·Ludmila Boublíková, Markéta Kalinová, Jacqueline Ryan, Fiona Quinn, Aengus O’Marcaigh, Owen Smith, Paul Browne, Jan Starý, Shaun R. McCann, Jan Trka, Mark Lawler	2005	75
10	Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology Blood ·Lenka Hovorková, Markéta Žaliová, Nicola C. Venn, Kirsten Bleckmann, Marie Trková, Eliška Potůčková, Martina Vašková, Jana Linhartová, Kateřina Machová Poláková, Eva Froňková, Walter Muskovic, Jodie E. Giles, Peter J. Shaw, Gunnar Cario, Rosemary Sutton, Jan Starý, Jan Trka, Jan Zuna	2017	73
11	Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia Haematologica ·Brian V. Balgobind, M. M. Van den Heuvel-Eibrink, R. X. De Menezes, Dirk Reinhardt, Iris H.I.M. Hollink, Susan T.C.J.M. Arentsen-Peters, Elisabeth R. van Wering, Gertjan J.L. Kaspers, Jacqueline Cloos, E. S. J. M. de Bont, JM Cayuela, André Baruchel, Claus Meyer, Rolf Marschalek, Jan Trka, Jan Starý, H. Berna Beverloo, R. Pieters, C. Michel Zwaan, Monique L. den Boer	2010	72
12	Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study Blood ·Jasmijn de Rooij, Riccardo Masetti, Marry M. van den Heuvel‐Eibrink, Jean-Michel Cayuela, Jan Trka, Dirk Reinhardt, Mareike Rasche, Edwin Sonneveld, Todd A. Alonzo, Maarten Fornerod, Martin Zimmermann, Martina Pigazzi, Rob Pieters, Soheil Meshinchi, C. Michel Zwaan, Franco Locatelli	2016	72
13	Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort Haematologica ·Markéta Žaliová, Jan Stuchlý, Lucie Winkowska, Alena Musilová, Karel Fišer, Martina Slámová, Júlia Starková, Martina Vašková, Ondřej Hrušák, Lucie Šrámková, Jan Starý, Jan Zuna, Jan Trka	2019	71
14	Detection of prognostically relevant genetic abnormalities in childhood B‐cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin‐Frankfürt‐Münster study group British Journal of Haematology ·Christine J. Harrison, Oskar A. Haas, Jochen Harbott, Andrea Biondi, Martin Stanulla, Jan Trka, Shai Izraeli	2010	66
15	CANCERTOOL: A Visualization and Representation Interface to Exploit Cancer Datasets Cancer Research ·Ana R. Cortázar, Verónica Torrano, Natalia Martín-Martín, Alfredo Caro‐Maldonado, Laura Camacho, Ivana Heřmanová, Elizabeth Guruceaga, L. Francisco Lorenzo‐Martín, Rubén Fernández, Roger R. Gomis, Iñigo Apaolaza, Vı́ctor Quesada, Jan Trka, Antonio Gómez‐Muñoz, Silvestre Vincent, Xosé R. Bustelo, Francisco J. Planes, Ana M. Aransay, Arkaitz Carracedo	2018	63
16	Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia Pediatric Blood & Cancer ·Lucie Šrámková, Kateřina Mužíková, Eva Froňková, Ondřej Krejčí, Petr Sedláček, Renata Formánková, Ester Mejstříková, Jan Starý, Jan Trka	2006	59
17	Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL Bone Marrow Transplantation ·Michaela Kotrová, Vincent H. J. van der Velden, Jacques J. M. van Dongen, Renata Formánková, Petr Sedláček, Monika Brüggemann, Jan Zuna, Jan Starý, Jan Trka, Eva Froňková	2017	58
18	EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia Leukemia ·Brian V. Balgobind, Sanne Lugthart, Iris H.I.M. Hollink, Susan T.J.C.M. Arentsen-Peters, Elisabeth R. van Wering, Siebold S.N. de Graaf, Dirk Reinhardt, Ursula Creutzig, Gertjan J.L. Kaspers, Eveline S.J.M. de Bont, Jan Starý, Jan Trka, M Zimmermann, H. Berna Beverloo, Rob Pieters, Ruud Delwel, C. Michel Zwaan, Marry M. van den Heuvel‐Eibrink	2010	57
19	High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia Blood ·Maaike Luesink, Iris H.I.M. Hollink, Vincent H. J. van der Velden, Ruth Knops, J.B.M. Boezeman, Válerie de Haas, Jan Trka, André Baruchel, Dirk Reinhardt, Bert A. van der Reijden, Marry M. van den Heuvel‐Eibrink, C. Michel Zwaan, Joop H. Jansen	2012	56
20	Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group Blood ·Nikola Hagedorn, Cécile Acquaviva, Eva Froňková, Arend von Stackelberg, Andrea Barth, Udo zur Stadt, André Schrauder, Jan Trka, Nathalie Gaspar, Karl Seeger, Günter Henze, Hélène Cavé, Cornelia Eckert	2007	53

About Jan Trka

Jan Trka is a scholar working on Public Health, Environmental and Occupational Health, Hematology, Molecular Biology, Pediatrics, Perinatology and Child Health and Pathology and Forensic Medicine, having authored 149 papers that have together received 3.7k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (104 papers), Acute Myeloid Leukemia Research (59 papers), Chronic Myeloid Leukemia Treatments (42 papers), Childhood Cancer Survivors' Quality of Life (24 papers), Lymphoma Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (12 papers), Renal and related cancers (10 papers) and Epigenetics and DNA Methylation (9 papers). The work is most often cited by research in Hematology (2.1k citations), Public Health, Environmental and Occupational Health (2.0k citations), Genetics (449 citations), Pediatrics, Perinatology and Child Health (654 citations) and Cancer Research (465 citations). Jan Trka has collaborated with scholars based in Czechia, Germany and Netherlands. Frequent co-authors include Jan Starý, Jan Zuna, Markéta Žaliová, Ondřej Hrušák, Júlia Starková, Dirk Reinhardt, Eva Froňková, Marry M. van den Heuvel‐Eibrink, Ester Mejstříková and Rob Pieters. Their work appears in journals such as Blood, Leukemia, Haematologica, Pediatric Blood & Cancer and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Jan Trka

Impact in

Papers in i

In The Last Decade

Jan Trka

Peers

Countries citing papers authored by Jan Trka

Fields of papers citing papers by Jan Trka

All Works

About Jan Trka

Explore authors with similar magnitude of impact

Papers in